本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ANI Pharmaceuticals, Inc.

64.96
-1.1400-1.72%
盘后64.960.00000.00%16:20 EDT
成交量:21.87万
成交额:1,422.06万
市值:14.07亿
市盈率:-62.29
高:66.01
开:65.55
低:64.39
收:66.10
数据加载中...
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/05

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/10/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/02

重要事件披露

Form 8-K - Current report